| Date | Event | Detail | Read |
|---|---|---|---|
| 16 May 2026 | FY26 audited results + concall | Consol. revenue ₹326.15 Cr (+12%), EBITDA ₹51 Cr (+7%), PBT ₹45 Cr (+7%), PAT ₹34.78 Cr (+12.5%). Final dividend ₹1.25/sh. | Positive |
| Q4 FY26 | Nine-quarter high revenue | Q4 revenue ₹101.4 Cr (+30% YoY); Q4 PAT +33% YoY. Water-treatment chemicals +~10% volume YoY tracking sector recovery. | Positive |
| 07 Apr 2025 | NCLT-approved demerger completed | Composite scheme: water technologies + construction chemicals + cleaning & hygiene + distribution housed in this entity (CHEMBONDCH). Metal-treatment/coatings/adhesives/biotech moved to Chembond Material Technologies. | Structural |
| FY26 | Order book commentary | Water Technologies (~87% of revenue) grew ~5% in FY26 supported by a strong order book; management pursuing expansion in construction chemicals and distribution. | Watch |
| Till 23 Jan 2027 | Promoter lock-in | Post-relisting promoter minimum lock-in runs ~18 months (per TradingView corporate-action panel). | Neutral |
Sources: company FY26 results & investor communication (May 2026), demerger scheme documents, market-data aggregators. Verify against BSE/NSE primary filings.
Chembond Chemicals Ltd (incorporated 1974, HQ Navi Mumbai) is a specialty-chemicals group. Following the composite scheme of arrangement that completed with NCLT approval in April 2025, the present listed entity (NSE: CHEMBONDCH) is a re-focused vehicle housing four businesses: Water Technologies, Construction Chemicals, Cleaning & Hygiene, and a Distribution arm. The legacy metal-treatment chemicals, coatings, industrial adhesives, sealants and biotech operations were carved into a separate listed company (Chembond Material Technologies). This makes CHEMBONDCH largely a water-treatment specialty-chemicals play — the water vertical contributes roughly 87% of consolidated revenue.
The water business supplies chemicals, dosing systems and services for industrial water treatment and reuse — covering raw, cooling, boiler, produced and waste water — with recent product launches including Kem Watreat® kits and the upgraded Chembond FLUX® monitor. It is a recurring-consumption, application-engineering model serving refineries, petrochemicals, fertilizers, power and general industry.
Why now: the demerger gives investors a cleaner, asset-light, debt-free water-treatment franchise riding India’s industrial water reuse / zero-liquid-discharge tailwind, with FY26 marking the first full year of the re-shaped business and a nine-quarter revenue high in Q4.
| Segment | Share of Revenue | Character |
|---|---|---|
| Water Technologies (chemicals + equipment + service) | ~87% | Recurring consumables + project/tender equipment |
| Construction Chemicals | ~ low double digit | Growth focus; cyclical to construction activity |
| Cleaning & Hygiene + Distribution | Balance | Distribution-led, lower margin |
Segment split is approximate, derived from management commentary; exact segmental disclosure should be verified in the FY26 annual report.
Water-treatment programs are embedded in customer plant operations with on-site service — Moderate.
Proprietary formulations & monitoring kits (Kem Watreat, FLUX) — Moderate.
Sub-₹500 Cr cap competing with far larger Wabag/Ion Exchange — Weak/niche.
Application-engineering led R&D; recent commercialised products include Kem Watreat® modular test kits and an upgraded Chembond FLUX® online monitor. Exact R&D spend as % of sales is not separately disclosed post-demerger. Pipeline data not fully disclosed — monitor earnings calls and the FY26 annual report.
Multiple specialty-chemical blending sites; asset-light model (fixed assets only ~₹23 Cr against ₹326 Cr revenue).
On-site water-treatment service teams — the recurring, sticky part of the model.
Dedicated distribution arm broadening reach across industrial customers.
Deepen recurring chemicals consumption + win equipment/tender orders.
Identified expansion vertical to diversify beyond water.
Fund expansion from internal accruals; preserve zero-debt balance sheet.
India’s industrial water-treatment and reuse market is structurally expanding, driven by tightening discharge norms (Zero Liquid Discharge mandates), water scarcity in industrial clusters, and rising reuse/recycle adoption across refining, fertilizer, power and chemicals. As a chemicals-and-service supplier, Chembond participates in the recurring-consumption layer of this theme rather than the lumpy EPC layer.
Volume recovery in water-treatment chemicals (+~10% Q4); margin holding ~15%.
Construction-chemicals scale-up + distribution leverage; first full multi-year record as a pure-play.
Structural ZLD/reuse adoption; potential to close the valuation gap to larger water peers if growth sustains.
The business is asset-light: net block ~₹23 Cr, no meaningful CWIP, and zero borrowings. Growth is being funded internally. Q4 FY26 revenue of ₹101.4 Cr was the highest in nine quarters, with management attributing momentum to a broad water-sector recovery and a healthy order book in the water vertical.
| Operational item | FY26 read | Signal |
|---|---|---|
| Capacity model | Asset-light blending + service; low fixed-asset intensity | Capital-efficient |
| Order book (water) | Described as “strong”; supported ~5% water growth | Monitor |
| Capex | No large announced capex; FCF ~₹1 Cr FY26 | Neutral |
Consolidated figures, ₹ Cr. FY24 onward reflect the re-shaped continuing business (post-demerger restatement) — the FY22→FY23→FY24 revenue step-down is a structural carve-out, not a demand collapse. Margins expanded sharply once the lower-margin demerged lines were removed.
| FY | Revenue | EBITDA | OPM% | PAT | PAT margin |
|---|---|---|---|---|---|
| FY22 | 349 | 17 | 5% | 14 | 4.0% |
| FY23 | 440 | 35 | 8% | 25 | 5.7% |
| FY24* | 283 | 42 | 15% | 30 | 10.6% |
| FY25 | 292 | 42 | 14% | 31 | 10.6% |
| FY26 | 326 | 47 | 15% | 35 | 10.7% |
*FY24/FY25 reflect continuing operations post carve-out. EPS FY26 ₹13.0 (face value ₹5).
| Driver | Mechanism | Direction |
|---|---|---|
| Zero Liquid Discharge (ZLD) norms | CPCB/SPCB tightening pushes industrial water reuse & chemical demand | Positive |
| Industrial water-reuse mandates | Refineries/fertilizer/power compelled to recycle — recurring chemicals demand | Positive |
| Input (crude-derivative) cost & import duties | Specialty-chemical feedstock price swings affect gross margin | Neutral / variable |
| Environmental compliance costs | Higher compliance overhead for manufacturing sites | Neutral |
No company-specific PLI scheme identified. Sector tailwind is regulation-led water reuse rather than a direct subsidy.
Institutional sell-side coverage of CHEMBONDCH is thin given the sub-₹500 Cr market cap and recent relisting. Available data is largely from market-data aggregators and company disclosures rather than broad brokerage consensus.
| Estimate (TradingView panel) | Jun-26 | Sep-26 |
|---|---|---|
| EPS growth (est.) | +87% | +62% |
| Sales growth (est.) | +55% | +39% |
Source: TradingView estimate panel — research framing only, not a recommendation. These are model estimates against a low prior-year base; treat as directional, not firm guidance. Verify against any formal broker notes.
| Item (₹ Cr) | FY26 | FY25 | FY24 |
|---|---|---|---|
| Equity capital | 13 | 13 | 13 |
| Reserves | 194 | 161 | 130 |
| Borrowings | 0 | 0 | 0 |
| Fixed assets | 23 | 21 | 22 |
| Investments | 30 | 35 | 27 |
| Other assets (incl. WC) | 200 | 157 | 131 |
| Total assets | 254 | 214 | 180 |
| ₹ Cr | FY26 | FY25 | FY24 |
|---|---|---|---|
| CFO | 8 | 10 | -56 |
| FCF | 1 | 5 | -75 |
| CFO/OP | 47% | 50% | -105% |
The big FY24 negative CFO is a demerger-year distortion. The persistent gap between PAT and operating cash — driven by rising debtor and working-capital days — is the single most important quality watch-item.
| Quarter | Revenue | QoQ | YoY | EBITDA | OPM% | PAT | EPS |
|---|---|---|---|---|---|---|---|
| Mar-26 | 101 | +18% | +30% | 16 | 16% | 12 | 4.36 |
| Dec-25 | 86 | +18% | +15% | 12 | 14% | 10 | 3.62 |
| Sep-25 | 73 | +12% | -3% | 11 | 15% | 7 | 2.70 |
| Jun-25 | 65 | -17% | +2% | 8 | 13% | 6 | 2.33 |
| Mar-25 | 78 | +4% | — | 12 | 16% | 9 | — |
| Dec-24 | 75 | 0% | — | 14 | 19% | 10 | — |
• Water Technologies (~87% of revenue) grew ~5%, supported by a strong order book.
• Q4 water-treatment chemicals saw ~+10% volume YoY tracking sector recovery.
• Management guiding to scale construction chemicals and distribution.
• H2 markedly stronger than H1; Q4 revenue a nine-quarter high.
| Metric | Current | Historical median | Read |
|---|---|---|---|
| P/E | 13.9x | ~12.1x | Slight premium |
| P/B | 2.6x | ~2.3x | Near median |
| EV/EBITDA | 8.5x | ~8.5x | At median |
TradingView composite-value model reads ~13% downside to fair value (₹156.9 FV on PE-est); Graham fair value ~₹141.8. These are model outputs, not recommendations.
| Company | Mkt Cap ₹Cr | P/E | ROCE% | ROE% | Model |
|---|---|---|---|---|---|
| Chembond Chemicals | 484 | 13.9 | 24 | 18 | Chemicals + service |
| VA Tech Wabag | 10,932 | 32.4 | 24 | 17.4 | Water EPC + O&M |
| Ion Exchange (India) | 5,357 | 36.1 | 13.4 | 11.2 | Resins + EPC + chemicals |
| Praj Industries | ~13,000 | ~35 | ~25 | ~20 | Bioenergy + water (adjacent) |
Chembond trades at a steep P/E discount to listed water peers, but it is a smaller, product-led supplier (not an EPC/O&M player) with weaker cash conversion — so part of the discount is structural. Praj figures are approximate. Source: Screener.in / public data — research framing only.
Chembond does not disclose a granular order-book number in aggregator data; management describes the water-vertical order book as “strong” and credits it for ~5% water-segment growth in FY26. The chemicals portion of revenue is recurring-consumption rather than discrete order-book, so book-to-bill is less central than for EPC peers.
| Metric | Read | Signal |
|---|---|---|
| Water order book | Described “strong”, supporting ~5% segment growth | Monitor |
| Revenue visibility | Recurring chemicals base + equipment/tender wins | Resilient |
| Q4 momentum | Nine-quarter high revenue; +10% chemical volume YoY | Improving |
Quantified order-intake disclosure is not available in aggregator feeds — track concall and the FY26 annual report for water-BU order-book figures (the FY filing references “New Order Book — Water Business Unit” line items).
Management is a long-standing promoter group (business since 1974). Post-demerger the standalone track record as a pure-play is short (essentially FY26 as the first full year), which limits guidance-accuracy scoring. Available signals:
| Claim / theme | FY26 outcome | Read |
|---|---|---|
| Water-sector recovery to drive volumes | Q4 chemical volume +~10% YoY; H2 >> H1 | ✅ Delivered |
| Margin discipline ~15% OPM | FY26 OPM ~15%; held through the year | ✅ Delivered |
| Grow construction chemicals / distribution | Stated priority; scale not yet evident in mix | ⚠ In progress |
| Cash conversion | CFO ₹8 Cr vs PAT ₹35 Cr; WC days rose | 🔴 Lagging |
✅ No guidance cuts evident ✅ No unexplained CFO/CEO change ✅ No promoter pledge ⚠ Working capital growing faster than revenue — watch related-party and receivable quality in the annual report.
CFO well below PAT (~0.23x) with WC days rising to 154. Reported profit is not fully translating to cash.
Mitigant: debt-free, so WC is self-funded; watch for normalisation in FY27.
Debtor days 99→128 over two years — concentration in slow-paying industrial/PSU clients risks write-downs.
Mitigant: diversified industrial base; no single-name disclosure of stress.
Sub-₹500 Cr cap competing with ₹5,000–11,000 Cr Wabag/Ion Exchange; limited bargaining and bid scale.
Mitigant: niche chemicals/service focus, not head-to-head EPC.
Crude-derivative feedstock swings can compress gross margin; pass-through lags.
Mitigant: OPM held ~15% through FY26.
Free float ~35%, low traded volumes (RVOL <1); price can be volatile and hard to exit.
Mitigant: promoter ~65% gives alignment.
Demerger completed Apr 2025 — limited multi-year track record as the re-shaped entity; estimates rest on a thin base.
Mitigant: 50-year operating legacy of the group.
Trades at a discount to peers; if growth disappoints the discount could persist or widen.
Mitigant: low absolute P/E vs peers cushions downside somewhat.
Research tracking milestones — not investment signals
| Milestone | Watch for | Timeline | Why it matters |
|---|---|---|---|
| FY26 annual report | Segmental split, water order book, receivable ageing | By Aug 2026 | Validates mix & quality of growth |
| Q1 FY27 results | Revenue >₹75 Cr & CFO catch-up | ~14 Aug 2026 | Tests whether H2FY26 momentum sustains |
| Working-capital normalisation | WC days back below ~120 | FY27 | Key to cash-conversion repair |
| Construction-chemicals scale-up | Visible revenue contribution in mix | FY27–28 | Diversification beyond water |
| Promoter lock-in expiry | Any supply event post Jan 2027 | Jan 2027 | Potential float/overhang change |
Detailed quarter-by-quarter shareholding was not retrievable from the data feed (login-gated). From the TradingView corporate panel the free float is ~35%, implying promoter holding of roughly ~65%, with a post-relisting promoter lock-in running to ~Jan 2027. No promoter pledge is flagged.
| Holder | Approx. stake | Note |
|---|---|---|
| Promoter group | ~65% | Lock-in to ~Jan 2027; aligned, no pledge flagged |
| Public / float | ~35% | Thin float, low daily volumes |
Verify exact FII/DII split in the latest BSE shareholding filing — institutional ownership is likely small given the size and recent relisting.
Scenario analysis — for research reference only. Not an investment recommendation.
Primary metric: P/E (profitable, asset-light product business). Scenarios anchor to FY27 earnings power and a multiple range from own history (trough), peer median, and an upper re-rating case. Values below mirror the TradingView scenario engine (1Y) and are illustrative.
WC stress + growth stall, sector de-rating.
1Y ~₹113 (−37%)
2Y ~₹94 · 3Y ~₹78
Mid-teens growth, OPM ~15%, multiple steady.
1Y ~₹190 (+6%)
2Y ~₹204 · 3Y ~₹218
Construction-chem ramp + cash-conversion repair + re-rating toward peers.
1Y ~₹289 (+61%)
2Y ~₹379 · 3Y ~₹497
Expected value (probability-weighted, TradingView model): ~₹208 (1Y). Triggers: Bear — two consecutive weak quarters / WC days >160; Base — guidance delivered ±10%; Bull — CFO/PAT >0.6 + construction-chem scale + re-rating. These are research scenarios, not price targets.
The point-VCP panel reads a BUY with the stock in an early Stage-2 advance after a prolonged Stage-3/4 base (the Aug-2025 launch → multi-month base → spring → recovery is visible on the chart). Current setup is a pullback into the fast moving average with volume drying up — constructive, but the higher-high/higher-low structure is still “unconfirmed” and there is no volume breakout yet.
| Indicator | Reading | Zone |
|---|---|---|
| Weekly TA consensus | Buy (score 0.42; MA 0.75, osc 0.09) | Constructive |
| Daily TA consensus | Neutral (0) | Balanced |
| Moving-average alignment (W) | Strongly bullish (MA score 0.75) | Bullish |
| Momentum | Recovering; TD Seq buy setup 9 | Turning up |
| Volume | Dry-up on pullback; no breakout volume yet | Watch |
| EMA distance (F/M/S) | -1.9% / -5.2% / -8.8% (price above slow EMA) | Healthy cushion |
52-week range: ₹104.85 (low) — CMP ₹180 — ₹245 (high). Price sits in the upper-middle of the range, ~26% below the 52W high. Note: outperforming the Midsmall400 but mildly lagging the broad CNX500 (RS -3.16%).
Research reference levels only. Supports: ₹168.5 / ₹163 / ₹158.8. Resistances: ₹200 / ₹208 / ₹227. 20-EMA(W) trail ~₹164. Fair-value model ~₹172.6.
| Symbol | TV signal | Score |
|---|---|---|
| CHEMBONDCH | Buy | 0.21 |
| VA Tech Wabag | Buy | 0.28 |
| Praj Industries | Neutral | -0.09 |
| Ion Exchange | Sell | -0.22 |
Among water peers, Chembond ranks second on combined daily+weekly TA — behind Wabag, ahead of Praj and Ion Exchange. It is outperforming the Midsmall400 but mildly lagging the CNX500; relative strength is improving off the base.
⚠️ For research reference only. These are not buy/sell recommendations.
₹180
Pullback-to-fast-MA reference
₹168.5
-6.5% · below setup low
₹203
+12.9% · ~2R
₹227 (+26%, ~4R)
₹250 (+39%, ~6R)
~1 : 2.4
| Event | Level | Significance |
|---|---|---|
| Confirms advance | Weekly close > ₹208 on above-average volume | Clears next resistance; confirms HH/HL |
| Invalidates setup | Weekly close < ₹163 / 20-EMA(W) ₹164 | Breaks base support; trend reference fails |
| Catalyst | Q1 FY27 results ~14 Aug 2026 | Earnings-driven move; PEAD is strong (>10%) |
Chembond Chemicals is a re-focused, debt-free water-treatment specialty-chemicals supplier created by the April-2025 demerger, with the water vertical now ~87% of revenue. FY26 was its first full year as a pure-play and ended on strong momentum — a nine-quarter-high Q4 (revenue +30%, PAT +33% YoY) with ~15% margins and high capital efficiency (ROCE ~24%). It trades at a steep P/E discount (13.9x) to far larger water peers (Wabag 32x, Ion Exchange 36x), but the discount is partly structural — smaller scale, thin float, a short standalone record, and notably weak cash conversion (CFO ~₹8 Cr against PAT ~₹35 Cr) as working-capital days climb. The research case rests on whether the company can convert profit into cash and scale its second engine (construction chemicals) while the water tailwind persists.